Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUOFAG in Surgical Wound Infections
NCT06319235Phase 2Recruiting
- Sponsor
- MB Pharma
- Start
- Oct 2023
- Primary completion
- Dec 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of DUOFAG in surgical site infection (SSI), sponsored by MB Pharma. Started Oct 2023; status: recruiting.
02
Drugs
DUOFAG
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT06319235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06319235.